| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-10 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-10 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |